Peter E Lipsky Selected Research

Systemic Lupus Erythematosus (Libman-Sacks Disease)

1/2023	Differential regulation of the interferon response in systemic lupus erythematosus distinguishes patients of Asian ancestry.
1/2023	Abnormalities in intron retention characterize patients with systemic lupus erythematosus.
4/2022	Biological impact of iberdomide in patients with active systemic lupus erythematosus.
1/2022	Anti-RNP antibodies are associated with the interferon gene signature but not decreased complement levels in SLE.
1/2022	Long-term follow-up after lymphodepleting autologous haematopoietic cell transplantation for treatment-resistant systemic lupus erythematosus.
11/2021	Transcriptomics data: pointing the way to subclassification and personalized medicine in systemic lupus erythematosus.
1/2021	Expression of Human Endogenous Retroviruses in Systemic Lupus Erythematosus: Multiomic Integration With Gene Expression.
10/2020	New insights into the role of antinuclear antibodies in systemic lupus erythematosus.
1/2020	Gut Microbiota and Bacterial DNA Suppress Autoimmunity by Stimulating Regulatory B Cells in a Murine Model of Lupus.
1/2020	Therapeutic implications of the anergic/postactivated status of B cells in systemic lupus erythematosus.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter E Lipsky Research Topics

Disease

38	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2023 - 05/2002
21	Gout 04/2024 - 08/2011
17	Autoimmune Diseases (Autoimmune Disease) 09/2023 - 01/2003
15	Rheumatoid Arthritis 10/2023 - 01/2002
10	Inflammation (Inflammations) 01/2023 - 05/2004
6	Pain (Aches) 01/2023 - 03/2019
6	Arthritis (Polyarthritis) 05/2022 - 01/2008
4	Lupus Nephritis 01/2023 - 01/2003
4	Proteinuria 01/2021 - 11/2003
3	Neoplasms (Cancer) 04/2024 - 09/2007
3	Disease Progression 01/2023 - 01/2017
3	Body Weight (Weight, Body) 01/2019 - 10/2002
3	Infections 12/2018 - 06/2006
3	Immunoglobulin G4-Related Disease 11/2018 - 11/2015
3	B-Cell Lymphoma (Lymphoma, B Cell) 11/2018 - 01/2006
2	Non-alcoholic Fatty Liver Disease 07/2023 - 01/2023
2	COVID-19 03/2023 - 01/2022
2	Autoimmune Hepatitis 01/2021 - 03/2006
2	Neutropenia 01/2021 - 02/2010
2	Vitamin D Deficiency 12/2018 - 08/2007
2	Communicable Diseases (Infectious Diseases) 01/2017 - 06/2008
2	Hypersensitivity (Allergy) 01/2017 - 05/2007
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 12/2012 - 02/2009
2	Rheumatic Diseases (Rheumatism) 01/2011 - 01/2006
2	Nephritis 06/2008 - 01/2006
2	Granuloma 06/2006 - 05/2004
2	Systemic Mastocytosis 06/2005 - 07/2002
1	Liver Cirrhosis (Hepatic Cirrhosis) 07/2023
1	Fatty Liver 07/2023
1	Lymphopenia (Lymphocytopenia) 03/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2023
1	Fibrosis (Cirrhosis) 01/2023
1	Gastroesophageal Reflux (GERD) 04/2022
1	Gouty Arthritis 11/2019

Drug/Important Bio-Agent (IBA)

15	AutoantibodiesIBA 01/2023 - 01/2003
13	Pegloticase FDA Link 01/2023 - 08/2011
13	Uric Acid (Urate)IBA 01/2023 - 08/2011
10	CytokinesIBA 03/2023 - 01/2003
7	Biomarkers (Surrogate Marker)IBA 03/2023 - 06/2004
6	Antinuclear AntibodiesIBA 10/2020 - 01/2017
5	InterferonsIBA 01/2023 - 01/2019
5	AutoantigensIBA 01/2020 - 01/2003
5	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 07/2002
4	Proteins (Proteins, Gene)FDA Link 10/2023 - 04/2004
4	Urate Oxidase (Uricase)IBA 01/2020 - 03/2014
4	Methotrexate (Mexate)FDA LinkGeneric 10/2018 - 09/2014
4	AntibodiesIBA 03/2014 - 08/2006
3	Nucleic AcidsIBA 01/2023 - 01/2010
3	anti-dsDNA autoantibodyIBA 01/2021 - 01/2006
3	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2019 - 03/2014
3	Messenger RNA (mRNA)IBA 11/2018 - 05/2002
3	interleukin-21 (interleukin 21)IBA 11/2018 - 11/2004
3	Immunoglobulin G (IgG)IBA 11/2018 - 01/2006
3	ChemokinesIBA 01/2009 - 01/2003
2	Anthocyanins (Anthocyanin)IBA 01/2023 - 07/2022
2	Complement System Proteins (Complement)IBA 01/2022 - 01/2019
2	Antirheumatic Agents (DMARD)IBA 01/2022 - 10/2018
2	Peptides (Polypeptides)IBA 01/2021 - 01/2008
2	Syk KinaseIBA 01/2020 - 12/2014
2	Allopurinol (Remid)FDA LinkGeneric 01/2020 - 08/2011
2	GlucocorticoidsIBA 02/2017 - 11/2015
2	MicroRNAs (MicroRNA)IBA 12/2010 - 05/2009
2	tocilizumab (atlizumab)FDA Link 02/2010 - 01/2006
2	triptolideIBA 06/2008 - 03/2007
2	DiterpenesIBA 06/2008 - 03/2007
2	NF-kappa B (NF-kB)IBA 01/2008 - 01/2004
2	Immunoglobulins (Immunoglobulin)IBA 03/2006 - 01/2003
1	Interleukin-1 (Interleukin 1)IBA 04/2024
1	Tumor Necrosis Factor InhibitorsIBA 10/2023
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2023
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 09/2023
1	Transaminases (Aminotransferases)IBA 07/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	canakinumab FDA Link 01/2023
1	rilonacept FDA Link 01/2023
1	Interleukin-10 (Interleukin 10)IBA 01/2023
1	AntioxidantsIBA 01/2023
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2023
1	Interferon Type IIBA 01/2023
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2023
1	Vitamin A (Retinol)FDA LinkGeneric 01/2023
1	Small Cytoplasmic RNAIBA 01/2023
1	iberdomideIBA 04/2022
1	Opioid Analgesics (Opioids)IBA 04/2022
1	CateninsIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Matrix Metalloproteinases (MMPs)IBA 01/2022
1	Colchicine FDA LinkGeneric 09/2021
1	Anti-Citrullinated Protein AntibodiesIBA 01/2021
1	Antigen-Antibody Complex (Immune Complex)IBA 10/2020
1	Vancomycin FDA LinkGeneric 01/2020
1	Bacterial DNAIBA 01/2020
1	Febuxostat FDA Link 01/2020

Therapy/Procedure

14	Therapeutics 04/2024 - 01/2002
2	Aftercare (After-Treatment) 01/2006 - 11/2003
1	Intra-Articular Injections 07/2022
1	Oral Administration 07/2022
1	Drug Therapy (Chemotherapy) 04/2022
1	Cell Transplantation 01/2022
1	Precision Medicine 11/2021